National Aspergillosis Centre - INCAS trial
@nacincas
INCAS is a Phase2 RCT (NCT05653193): adjunctive interferon gamma to treat chronic pulmonary aspergillosis
Based at @MFT_NAC (@MFTnhs), funded by @NIHRresearch
ID: 1573224275502370819
23-09-2022 08:14:41
156 Tweet
63 Followers
212 Following